Utah Medical Products (UTMD) Invested Capital (2016 - 2025)
Historic Invested Capital for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $118.3 million.
- Utah Medical Products' Invested Capital fell 478.68% to $118.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $118.3 million, marking a year-over-year decrease of 478.68%. This contributed to the annual value of $117.4 million for FY2024, which is 848.39% down from last year.
- Per Utah Medical Products' latest filing, its Invested Capital stood at $118.3 million for Q3 2025, which was down 478.68% from $117.5 million recorded in Q2 2025.
- In the past 5 years, Utah Medical Products' Invested Capital registered a high of $128.3 million during Q4 2023, and its lowest value of $104.9 million during Q1 2021.
- Over the past 5 years, Utah Medical Products' median Invested Capital value was $117.4 million (recorded in 2024), while the average stood at $116.1 million.
- Per our database at Business Quant, Utah Medical Products' Invested Capital skyrocketed by 1434.2% in 2023 and then tumbled by 848.39% in 2024.
- Quarter analysis of 5 years shows Utah Medical Products' Invested Capital stood at $107.1 million in 2021, then grew by 6.64% to $114.3 million in 2022, then increased by 12.3% to $128.3 million in 2023, then decreased by 8.48% to $117.4 million in 2024, then rose by 0.7% to $118.3 million in 2025.
- Its Invested Capital stands at $118.3 million for Q3 2025, versus $117.5 million for Q2 2025 and $117.0 million for Q1 2025.